Roche to Expand Ponce Operations
SAN JUAN — Pharmaceutical company Roche will invest $60 million to expand its site in Ponce, aiming to create 40 new jobs when construction work is finalized in 2018.
“The medicine of the future will be manufactured in Ponce. Once again, it would be Puerto Rican hands that will provide relief, health and a better quality of life to a large percentage of the population,” said Gov. Alejandro García Padilla, who visited the pharmaceutical company’s facilities Tuesday.
With the expansion, Roche’s Ponce operations would help in the manufacturing of the next generation of Accu-Chek glucose-monitoring strips developed by the Swiss company, which has had a 45-year presence in Puerto Rico.
The Accu-Chek brand portfolio offers people with diabetes and healthcare professionals products for diabetes management, spanning from blood glucose monitoring through information management to insulin delivery.
“Roche [local operations] will open its doors to the European market thanks to the increased production capacity and the possibility to develop more specialized products related to diabetes,” said the governor, who emphasized his administration’s efforts to promote Puerto Rico as an investment option for manufacturing companies.
Emphasizing his push since Day 1 for the creation of jobs and responsible public management, García Padilla said he is convinced the first steps needed for the transformation and development of Puerto Rico have taken place under his administration.
“Roche’s expansion, as well as the others announced, along with the arrival of new industries, confirm this,” the governor stated.
Bristol-Myers Squibb also recently announced it is investing nearly $80 million to expand its local plant, and pharmaceutical and laboratory equipment supplier Sartorius said it is investing some $50 million to convert its Yauco plant into a logistics hub.